5-MAPB also known as 5-(2-methylaminopropyl) benzofuran, is a synthetic entactogen of the benzofuran class. 5-MAPB is known for its stimulating, euphoric and entactogenic outcomes. 5-MAPB
includes MDA-inspired substances as 5-APB, 6-APB and 5-EAPB, among others. 5-MAPB has been rising in popularity as a research chemical since 2010. 5-MAPB is structurally similar to
3,4-Methyl​enedioxy​methamphetamine, also known as Molly or MDMA, first developed in 1912 by Merck. In theory, t acts primarily by increasing the neurotransmitters serotonin, dopamine, and
noradrenaline activity and belongs to the substituted amphetamine classes. Researchers have reported that 5-MAPB has the same stimulant and hallucinogenic outcomes.